It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Genomic sequencing reveals mutations, insights into 2014 Ebola outbreak
To accelerate response efforts, the research team released the full-length sequences on National Center for Biotechnology Information’s (NCBI’s) DNA sequence database in advance of publication, making these data available to the global scientific community.
“By making the data immediately available to the community, we hope to accelerate response efforts,” said co-senior author Pardis Sabeti, a senior associate member at the Broad Institute and an associate professor at Harvard University. “Upon releasing our first batch of Ebola sequences in June, some of the world’s leading epidemic specialists contacted us, and many of them are now also actively working on the data. We were honored and encouraged. A spirit of international and multidisciplinary collaboration is needed to quickly shed light on the ongoing outbreak.”
Where Did Ebola Come From? Likely One Person, Gene Study Finds
........the Ebola virus strain in West Africa appears to be mutating twice as fast as it did in the past when it lived in an animal “reservoir,” probably a bat.
“It’s going to change,” Garry said. “A human being is not a bat. The longer this virus is allowed to propagate human to human, the more it is going to adapt.”
Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak
....We observed a rapid accumulation of interhost and intrahost genetic variation, allowing us to characterize patterns of viral transmission over the initial weeks of the epidemic. This West African variant likely diverged from Middle African lineages ~2004, crossed from Guinea to Sierra Leone in May 2014, and has exhibited sustained human-to-human transmission subsequently, with no evidence of additional zoonotic sources. Since many of the mutations alter protein sequences and other biologically meaningful targets, they should be monitored for impact on diagnostics, vaccines, and therapies critical to outbreak response.
originally posted by: Vasa Croe
Yay! Next up....airborne mutation, unless of course that has already happened and we just are not being told about it. Get ready for this to hit in a large city near you!
As of 26 August 2014, the cumulative number of cases attributed to EVD in the four countries stands at 3069, including 1552 deaths.
It is the largest known EVD outbreak and is expanding exponentially with a doubling period of 34.8 days (Fig. 1B).
originally posted by: 727Sky
Thanks for staying on top of this. ....I also read many of the international airlines have canceled their flights to certain countries in Africa.. We will see if it was to little to late...
Ebola virus (EBOV; formerly Zaire ebolavirus), one of five ebolaviruses, is a lethal human pathogen, causing Ebola virus disease (EVD) with an average case fatality rate of 78%
originally posted by: soficrow
The action of releasing what's normally "secret" information protected by Intellectual Property law represents an astounding paradigm shift. This is a game changer. And anyone who knows anything will recognize this actions means the situation is desperately dire.
(CNN) -- The West African country of Senegal has confirmed its first Ebola case one week after closing its borders with Guinea over fears that the deadly outbreak could spread, the Senegalese Press Agency reported Friday.
Senegal's health minister, Awa Marie Coll Seck, confirmed that a 21-year-old university student from Guinea was infected with the Ebola virus and placed in quarantine in the Fann Hospital in Dakar, the news agency reported.
Officials in Guinea alerted Senegal on August 27 after losing track of the young man, the agency reported.
The overall fatality rate is 52%, the WHO said, ranging from 42% in Sierra Leone to 66% in Guinea.
originally posted by: Serdgiam
originally posted by: soficrow
The action of releasing what's normally "secret" information protected by Intellectual Property law represents an astounding paradigm shift. This is a game changer. And anyone who knows anything will recognize this actions means the situation is desperately dire.
It is most definitely a shift in paradigm. One that has been bubbling to the surface for a while.
While this situation is dire, it is not this specific scenario that has spurred this on. .....
originally posted by: soficrow
The push for 'Open Access' to scientific information is an old one, sure, and I've done my share over the past decade to promote it. But I doubt this research would have opened up to the global community unless the current situation pretty much demanded it. It is a real sign of the current desperate need.
originally posted by: soficrow
a reply to: joho99
Ah. That's standard 'old' Zaire. One of the many ways this ZEBOV epidemic is different is that it has a fatality rate around 52% (not 47% as I said earlier), depending on the location. Or timing? Maybe it's becoming less fatal?
The overall fatality rate is 52%, the WHO said, ranging from 42% in Sierra Leone to 66% in Guinea.
The trade-off hypothesis suggests that there is a trade off between how long the virus or other pathogen is able to persist in its host and the rate at which the virus or other pathogen can be transmitted. The trade off hypothesis suggests that virulence will evolve to a level at which virulence and transmission is balanced so as to maximize the spread of the virus.
Viral lines with the higher enforced rate of infectious transmission evolved higher virulence and higher rates of virus production. These results support the trade-off model for the evolution of virulence.
Following the introduction of Ebola virus in the human population through animal-to-human transmission, person-to-person transmission by direct contact bodily fluids/secretions of infected persons is considered the principal mode of transmission. Indirect contact with environment and fomites soiled with contaminated bodily fluids (e.g. needles) may also occur. Airborne transmission has not been documented during previous EVD outbreaks.
There is no risk of transmission during the incubation period.